Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 877,700 | 747,100 | 419,200 | 1,280,600 | 2,379,500 |
| Depreciation Amortization | 681,100 | 643,500 | 577,300 | 537,200 | 577,000 |
| Income taxes - deferred | 97,600 | -20,100 | -78,100 | 26,300 | -37,300 |
| Accounts receivable | -122,200 | -21,900 | -75,300 | 23,100 | 226,300 |
| Accounts payable and accrued liabilities | -52,800 | 72,100 | -42,400 | 285,400 | -5,300 |
| Other Working Capital | -526,100 | -154,100 | -361,900 | -353,200 | -187,900 |
| Other Operating Activity | 685,200 | 319,200 | 888,900 | 156,500 | 157,300 |
| Operating Cash Flow | $1,640,500 | $1,585,800 | $1,327,700 | $1,955,900 | $3,109,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -185,500 | -55,000 | -22,300 | -17,400 | -27,800 |
| PPE Investments | -426,500 | -487,900 | -453,000 | -427,900 | -334,200 |
| Net Acquisitions | -582,000 | -823,900 | -671,500 | -1,162,400 | -496,900 |
| Sale Of Investment | N/A | N/A | N/A | 5,200 | 13,200 |
| Other Investing Activity | 0 | 0 | -24,700 | -49,700 | -38,900 |
| Investing Cash Flow | $-1,194,000 | $-1,366,800 | $-1,171,500 | $-1,652,200 | $-884,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 64,800 | 4,463,700 | 2,488,200 | 787,400 | 1,000,000 |
| Debt Repayment | -1,064,800 | -3,463,700 | -2,788,200 | -787,400 | -1,375,000 |
| Common Stock Issued | 54,300 | 56,200 | 54,400 | 50,600 | 51,700 |
| Common Stock Repurchased | -450,000 | -250,100 | -1,000,000 | -1,100,000 | -1,668,500 |
| Dividend Paid | -240,700 | -243,100 | -254,000 | -195,200 | N/A |
| Other Financing Activity | 179,400 | 216,900 | 1,440,300 | -77,600 | -74,000 |
| Financing Cash Flow | $-1,457,000 | $779,900 | $-59,300 | $-1,322,200 | $-2,065,800 |
| Exchange Rate Effect | 24,100 | -17,000 | 9,900 | -24,200 | -7,300 |
| Beginning Cash Position | 1,518,700 | 536,800 | 430,000 | 1,363,300 | 1,229,500 |
| End Cash Position | 532,300 | 1,518,700 | 536,800 | 320,600 | 1,381,400 |
| Net Cash Flow | $-986,400 | $981,900 | $106,800 | $-1,042,700 | $151,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,640,500 | 1,585,800 | 1,327,700 | 1,955,900 | 3,109,600 |
| Capital Expenditure | -434,500 | -489,900 | -453,600 | -429,300 | -421,500 |
| Free Cash Flow | 1,206,000 | 1,095,900 | 874,100 | 1,526,600 | 2,688,100 |